Form 4 for TNXP Tonix Pharmaceuticals Holding Corp.
Accepted 2022-03-28 00:00:00 ET · period of report 2022-03-25 · accession 0001387131-22-003991 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-03-28 | 2022-03-25 | TNXP | LEDERMAN SETH | CEO, Dir | P - Purchase | $0.25 | +100.0K | 112.2K | +821% | +$25.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, $0.001 par value | 2022-03-25 | P | A | 100,000 | $0.25 | 112,177 | D | — | — |